Hope for a COVID-19 vaccine attracts investors to Cambridge biotech

The eight were study participants who received a potential COVID-19 vaccine and produced antibodies that killed the coronavirus in a laboratory dish. Within hours of issuing a press release about this finding, Moderna, the Cambridge-based maker of the ...

from Google Alert - Business https://ift.tt/36gB7YH
The eight were study participants who received a potential COVID-19 vaccine and produced antibodies that killed the coronavirus in a laboratory dish. Within hours of issuing a press release about this finding, Moderna, the Cambridge-based maker of the ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize